Showing results (231-240 of 9,917) with videos related to
Sort By:
Pageof 992
Bone Marrow Transplantation|August 21, 2007
Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantationG Michel, P Bordigoni, M-C Simeoni, et al.Bone Marrow Transplantation|July 20, 2007
Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantationR T Kamble, D A Clark, H N Leong, et al.Bone Marrow Transplantation|July 20, 2007
Kinetics of peg-filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplantationN Piccirillo, S De Matteis, S De Vita, et al.Bone Marrow Transplantation|July 20, 2007
Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplantB P Soule, N L Simone, B N Savani, et al.Bone Marrow Transplantation|July 31, 2007
Event-free survival and cost-effectiveness in adult acute lymphoblastic leukaemia in first remission treated with allogeneic transplantationC Orsi, B Bartolozzi, A Messori, et al.Bone Marrow Transplantation|July 31, 2007
Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disordersL M Burroughs, R Storb, W M Leisenring, et al.Bone Marrow Transplantation|July 25, 2007
Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height lossP S Maclean, A N Parker, I G McQuaker, et al.Bone Marrow Transplantation|July 3, 2007
Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantationE Jabbour, G Rondon, P Anderlini, et al.Bone Marrow Transplantation|August 1, 2006
Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimensA Nosari, R Cairoli, D Ciapanna, et al.Pageof 992